How vaccine campaigns could reduce COVID-19 infections
New research examines how COVID-19 infections and hospitalisations could be reduced through national vaccine campaigns.
New research examines how COVID-19 infections and hospitalisations could be reduced through national vaccine campaigns.
On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially declared a pandemic.
Around 5–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more.
The long-awaited independent inquiry into Australia’s COVID response was released today, with lessons on how the nation could better prepare for future pandemics.
With long COVID estimated to impact 5–10% of Australians infected by the SARS-CoV-2 virus, it is vital to monitor the incidence and effects of long COVID, leading to better support for patients and general practice.
COVID vaccines have unquestionably made a huge difference during this pandemic. For example, it’s estimated COVID shots have saved more than 1.4 million lives in the World Health Organization’s (WHO) European region alone since their introduction in December 2020.
The health system needs to take an ‘all hands on deck’ approach to ensure at-risk people in aged care communities have prompt access to vaccination, testing and treatment for COVID-19.
COVID-19 continues to contribute to higher mortality rates among people admitted to intensive care units, even when COVID-19 is not the primary reason for their admission.
Throughout the pandemic, one of the key questions on everyone’s mind was why some people avoided getting COVID, while others caught the virus multiple times.